{"id":52675,"date":"2026-01-04T14:03:27","date_gmt":"2026-01-04T06:03:27","guid":{"rendered":"https:\/\/flcube.com\/?p=52675"},"modified":"2026-01-04T14:03:28","modified_gmt":"2026-01-04T06:03:28","slug":"china-state-council-approves-revised-drug-administration-regulations-accelerating-innovation-review","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=52675","title":{"rendered":"China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review"},"content":{"rendered":"\n<p>The <strong>State Council of China<\/strong> approved the <strong>Revised Draft of the Implementation Regulations of the Drug Administration Law<\/strong> at its executive meeting held on December\u202f31, 2025, marking a landmark update to the country\u2019s pharmaceutical regulatory framework that will <strong>expedite breakthrough drug approvals<\/strong> while strengthening <strong>full\u2011chain quality supervision<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-milestone\">Regulatory Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Regulatory Body<\/strong><\/td><td>State Council of China<\/td><\/tr><tr><td><strong>Document<\/strong><\/td><td>Revised Implementation Regulations of the Drug Administration Law of PRC<\/td><\/tr><tr><td><strong>Approval Date<\/strong><\/td><td>31\u202fDec\u202f2025<\/td><\/tr><tr><td><strong>Public Comment Period<\/strong><\/td><td>Originally open for comment May\u202f2022<\/td><\/tr><tr><td><strong>Primary Objectives<\/strong><\/td><td>Accelerate innovation review, strengthen quality supervision, combat illegal activities<\/td><\/tr><tr><td><strong>Effective Timeline<\/strong><\/td><td>Expected Q1\u202f2026 (pending final gazette)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-provisions-amp-industry-impact\">Key Provisions &amp; Industry Impact<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-innovation-catalyst\"><strong>Innovation Catalyst<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Expedited Pathway<\/strong>: Establishes clearer framework for <strong>priority review<\/strong> of breakthrough therapeutic drugs<\/li>\n\n\n\n<li><strong>Registration Reform<\/strong>: Improves drug research and registration system to reduce approval timelines by an estimated <strong>6\u201112 months<\/strong><\/li>\n\n\n\n<li><strong>Investment Signal<\/strong>: Policy certainty encourages bold R&amp;D investment, accelerating transition from <strong>&#8220;imitation to innovation&#8221;<\/strong><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-quality-amp-supervision\"><strong>Quality &amp; Supervision<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Full\u2011Chain Oversight<\/strong>: Mandates strict quality management from <strong>R&amp;D to clinical use<\/strong> across entire supply chain<\/li>\n\n\n\n<li><strong>High\u2011Pressure Enforcement<\/strong>: Maintains stringent regulatory stance with <strong>severe crackdowns<\/strong> on pharmaceutical illegal activities<\/li>\n\n\n\n<li><strong>Legal Foundation<\/strong>: Consolidates &#8220;stringent requirements&#8221; into &#8220;rigid systems&#8221; for more robust enforcement<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-market-implications\"><strong>Market Implications<\/strong><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Stakeholder<\/th><th>Impact<\/th><\/tr><\/thead><tbody><tr><td><strong>Innovative Drug Developers<\/strong><\/td><td>Faster market access, reduced regulatory uncertainty<\/td><\/tr><tr><td><strong>Generic Manufacturers<\/strong><\/td><td>Increased compliance costs, quality bar elevation<\/td><\/tr><tr><td><strong>Multinational Pharma<\/strong><\/td><td>Streamlined entry for breakthrough therapies<\/td><\/tr><tr><td><strong>Patients<\/strong><\/td><td>Improved drug safety, faster access to novel treatments<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-significance\">Strategic Significance<\/h2>\n\n\n\n<p><strong>Domestic Industry Upgrade<\/strong>: The revision directly supports China&#8217;s <strong>&#8220;Healthy China 2030&#8221;<\/strong> initiative by strengthening the domestic pharmaceutical industry&#8217;s innovation capacity. By embedding expedited review mechanisms into law, the government aims to:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Increase R&amp;D Productivity<\/strong>: Reduce time\u2011to\u2011market for innovative drugs from <strong>8\u201110 years to 5\u20117 years<\/strong><\/li>\n\n\n\n<li><strong>Enhance Global Competitiveness<\/strong>: Position China as a <strong>top\u20113 global innovation hub<\/strong> by 2030<\/li>\n\n\n\n<li><strong>Patient Safety<\/strong>: Directly safeguard public medication safety through <strong>mandatory traceability<\/strong> and ** pharmacovigilance** systems<\/li>\n<\/ol>\n\n\n\n<p><strong>Investment Flow<\/strong>: Analysts project the reforms will unlock an additional <strong>\u00a550\u201180 billion<\/strong> in venture capital and corporate R&amp;D spending over the next 3 years, focusing on <strong>oncology, rare diseases, and cell\/gene therapies<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h2>\n\n\n\n<p>This brief contains forward\u2011looking assessments regarding the implementation timeline, market impact, and industry transformation resulting from the revised drug administration regulations. Actual outcomes may differ due to regulatory interpretation, enforcement intensity, and global pharmaceutical market dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The State Council of China approved the Revised Draft of the Implementation Regulations of the&#8230;<\/p>\n","protected":false},"author":1,"featured_media":52687,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[59],"class_list":["post-52675","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-state-council"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The State Council of China approved the Revised Draft of the Implementation Regulations of the Drug Administration Law at its executive meeting held on December\u202f31, 2025, marking a landmark update to the country\u2019s pharmaceutical regulatory framework that will expedite breakthrough drug approvals while strengthening full\u2011chain quality supervision.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=52675\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review\" \/>\n<meta property=\"og:description\" content=\"The State Council of China approved the Revised Draft of the Implementation Regulations of the Drug Administration Law at its executive meeting held on December\u202f31, 2025, marking a landmark update to the country\u2019s pharmaceutical regulatory framework that will expedite breakthrough drug approvals while strengthening full\u2011chain quality supervision.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=52675\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-04T06:03:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-04T06:03:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/0401.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52675#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52675\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review\",\"datePublished\":\"2026-01-04T06:03:27+00:00\",\"dateModified\":\"2026-01-04T06:03:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52675\"},\"wordCount\":396,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52675#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/0401.webp\",\"keywords\":[\"State Council\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=52675#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52675\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=52675\",\"name\":\"China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52675#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52675#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/0401.webp\",\"datePublished\":\"2026-01-04T06:03:27+00:00\",\"dateModified\":\"2026-01-04T06:03:28+00:00\",\"description\":\"The State Council of China approved the Revised Draft of the Implementation Regulations of the Drug Administration Law at its executive meeting held on December\u202f31, 2025, marking a landmark update to the country\u2019s pharmaceutical regulatory framework that will expedite breakthrough drug approvals while strengthening full\u2011chain quality supervision.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52675#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=52675\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52675#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/0401.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/0401.webp\",\"width\":1080,\"height\":608,\"caption\":\"China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=52675#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review - Insight, China&#039;s Pharmaceutical Industry","description":"The State Council of China approved the Revised Draft of the Implementation Regulations of the Drug Administration Law at its executive meeting held on December\u202f31, 2025, marking a landmark update to the country\u2019s pharmaceutical regulatory framework that will expedite breakthrough drug approvals while strengthening full\u2011chain quality supervision.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=52675","og_locale":"en_US","og_type":"article","og_title":"China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review","og_description":"The State Council of China approved the Revised Draft of the Implementation Regulations of the Drug Administration Law at its executive meeting held on December\u202f31, 2025, marking a landmark update to the country\u2019s pharmaceutical regulatory framework that will expedite breakthrough drug approvals while strengthening full\u2011chain quality supervision.","og_url":"https:\/\/flcube.com\/?p=52675","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-04T06:03:27+00:00","article_modified_time":"2026-01-04T06:03:28+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/0401.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=52675#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=52675"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review","datePublished":"2026-01-04T06:03:27+00:00","dateModified":"2026-01-04T06:03:28+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=52675"},"wordCount":396,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=52675#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/0401.webp","keywords":["State Council"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=52675#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=52675","url":"https:\/\/flcube.com\/?p=52675","name":"China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=52675#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=52675#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/0401.webp","datePublished":"2026-01-04T06:03:27+00:00","dateModified":"2026-01-04T06:03:28+00:00","description":"The State Council of China approved the Revised Draft of the Implementation Regulations of the Drug Administration Law at its executive meeting held on December\u202f31, 2025, marking a landmark update to the country\u2019s pharmaceutical regulatory framework that will expedite breakthrough drug approvals while strengthening full\u2011chain quality supervision.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=52675#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=52675"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=52675#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/0401.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/0401.webp","width":1080,"height":608,"caption":"China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=52675#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China State Council Approves Revised Drug Administration Regulations, Accelerating Innovation Review"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/0401.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52675","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=52675"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52675\/revisions"}],"predecessor-version":[{"id":52688,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/52675\/revisions\/52688"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/52687"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=52675"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=52675"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=52675"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}